These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 24752754)

  • 1. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
    Rojas DC
    J Neural Transm (Vienna); 2014 Aug; 121(8):891-905. PubMed ID: 24752754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.
    Montanari M; Martella G; Bonsi P; Meringolo M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy.
    Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):525-35. PubMed ID: 9720980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New glutamatergic target for alcohol and substance use disorder medications.
    Vadasz C; Saito M
    Psychopharmacology (Berl); 2014 Apr; 231(7):1429-31. PubMed ID: 24619644
    [No Abstract]   [Full Text] [Related]  

  • 5. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.
    Heresco-Levy U
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):827-44. PubMed ID: 16262565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism.
    Purcell AE; Jeon OH; Zimmerman AW; Blue ME; Pevsner J
    Neurology; 2001 Nov; 57(9):1618-28. PubMed ID: 11706102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X disappointments upset autism ambitions.
    Mullard A
    Nat Rev Drug Discov; 2015 Mar; 14(3):151-3. PubMed ID: 25722228
    [No Abstract]   [Full Text] [Related]  

  • 8. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome.
    Hampson DR; Adusei DC; Pacey LK
    Biochem Pharmacol; 2011 May; 81(9):1078-86. PubMed ID: 21333634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of glutamate and its receptors in autism spectrum disorder.
    Nisar S; Bhat AA; Masoodi T; Hashem S; Akhtar S; Ali TA; Amjad S; Chawla S; Bagga P; Frenneaux MP; Reddy R; Fakhro K; Haris M
    Mol Psychiatry; 2022 May; 27(5):2380-2392. PubMed ID: 35296811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate: the new frontier in pharmacotherapy for cocaine addiction.
    Uys JD; LaLumiere RT
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):482-91. PubMed ID: 19128205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Also Topiramate might have some benefit in psychopharmacological treatment of autism.
    Niederhofer H
    Med Hypotheses; 2008; 70(2):455. PubMed ID: 17656029
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
    Paslakis G; Gass P; Deuschle M
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article.
    Chizh BA
    Amino Acids; 2002; 23(1-3):169-76. PubMed ID: 12373533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Group I Metabotropic Glutamate Receptors Reverses Autistic-Like Phenotypes Caused by Deficiency of the Translation Repressor eIF4E Binding Protein 2.
    Aguilar-Valles A; Matta-Camacho E; Khoutorsky A; Gkogkas C; Nader K; Lacaille JC; Sonenberg N
    J Neurosci; 2015 Aug; 35(31):11125-32. PubMed ID: 26245973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of glutamate receptors: strategies for the development of novel antidepressants.
    Skolnick P
    Amino Acids; 2002; 23(1-3):153-9. PubMed ID: 12373530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate and the glutamate receptor system: a target for drug action.
    Bleich S; Römer K; Wiltfang J; Kornhuber J
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S33-40. PubMed ID: 12973748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic theories of schizophrenia.
    Javitt DC
    Isr J Psychiatry Relat Sci; 2010; 47(1):4-16. PubMed ID: 20686195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal glutamate release in aged BTBR mouse model of autism.
    Wei H; Ding C; Jin G; Yin H; Liu J; Hu F
    Int J Clin Exp Pathol; 2015; 8(9):10689-97. PubMed ID: 26617779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Glutamate Receptors in Parkinson's Disease.
    Zhang Z; Zhang S; Fu P; Zhang Z; Lin K; Ko JK; Yung KK
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.